苦参抗肿瘤机制的研究进展.pdfVIP

2·80 · MOD ERN ONCOLO GY, Ap r2005, VO I13, NO 2 lymp hocyte activation [ J ]. J Exp M ed. 2000 , 192 , 1027 - 1034. tor affects dendritic cell m atu ration through the inh ib ition of nucle [ 8 ] 　Zou W. Strom al - derived factor - 1 in hum an tumors recru its and ar factor - kapp a B activation in hem atopoietic p rogen itor cells alters the function of p lasm acytoid p recu rsor dendritic cells [ J ]. [ J ]. J Immunol, 1998, 160: 1224. N at M ed, 200 1, 7: 1339 ～1346. [ 15 ] 　 Gab rilovich D , Ish ida T, Oyam a T, et a l. V ascu lar endothelial [ 9 ] 　Cu riel TJ , W ei S, Dong H , et a l . B lockade of B7 - H 1 imp roves grow th factor inh ib its the developm ent of dendritic cells and dra myeloid dendritic cell - m ediated antitumor immun ity [ J ]. N at m atically affects the differentiation of mu ltip le hem atopoietic lin M ed, 2003 , 9 ( 5) : 562 ～567. eages in vivo [ J ]. B lood, 1998, 92: 4 150 [ 10 ] 　Schonbeck U. the CD40 / CD l54 recep tor/ lignd dyad. Cell Mol [ 16 ] 　 Ino sh im a N , N akan ish i Y, M inam i T, et a l. The influence of L ife Sci, 200 1, 58: 4 ～43. dendritic cell infiltration and vascu lar endothelial grow th factor [ 11 ] 　H aase C, M ichelsen BK, Jorgen sen TN. CD40 is necessary for exp ression on the p rognosis of non - sm all cell lung cancer [ J ]. activation of naive T cells by a dendritic cell line in vivo bu t not C lin Cancer R es, 2002 , 8 ( 11) : 3480 ～3496. in vitro [ J ]. Scand J Immunol, 2004 , 59 ( 3) : 237 ～245. [ 17 ] 　M akarenkova V P, Shurin GV , Tou rkova IL , et a l. Lung cancer [ 12 ] 　Tada Y, O - W ang J , Yu L , et a l. T - cell - dep endent antitu - derived bom